• Diagnosis and prognosis for each ophthalmogenetic disease depends on identifying the underlying genetic cause
  • Up to recently genetic testing has been selective and largely ineffective
  • Massive genomic testing of several genes, which we now know to be associated with various ophthalmogenetic diseases, leads in a single step to successful diagnosis

Genetic diseases involving the eyes (and/or with the involvement of the eyes) are relatively common, making them the leading cause of blindness in children and adults, albeit with considerable clinical and genetic heterogeneity.

A large number of retinal diseases, such as retinitis pigmentosa, cone-rod dystrophy, colorblindness, etc., lead to degeneration of the photoreceptor and it is often difficult to distinguish the specific type.

More than 90 different types of retinitis pigmentosa have been described and more than 60 genes have been implicated.

Similarly, Leber congenital amaurosis (LCA) is associated with approximately 12 to 15 genes and the disease is characterized by congenital loss of vision and over time it may also manifest with severe macular degeneration and retinopathy.

Most genetic disorders of the eyes are not yet treatable and/or have no discreet therapeutic approaches, mainly due to our limited understanding of the disease mechanisms.

Ophthalmologists, particularly pediatric ophthalmologists, are often the ones who are at the forefront of patient evaluation and of the families burdened with such disorders.

The genetic basis of ophthalmogenetic diseases

Currently, there are several genes in which mutations are known to be associated with one or more ophthalmogenetic diseases. The broader categories of the disorders included in this group are:

  • all known types of retinitis pigmentosa,
  • all the different types of cone and cone-rod dystrophies,
  • all types of Leber congenital amaurosis
  • all macular diseases
  • retinoblastoma, and generally diseases affecting the eyes/vision with a genetic etiology

The mode of inheritance varies and includes all possible types: autosomal recessive, autosomal dominant and sex-linked.

Ophthalmogenetic diseases are particularly complex as to their genetic etiology, since mutations in different genes may lead to similar clinical symptoms, while different mutations in a single gene lead to different clinical manifestations.

Also, the severity of the disease may differ between patients with the same mutation, due to the possible presence of other modifying genetic factors.

Finally, there are cases with digenic inheritance, where mutations in two different genes are required for disease manifestation.

Why is genetic testing in ophthalmogenetic diseases important ?

In view of the nature, severity and complexity of these diseases, genetic testing for ophthalmogenetic diseases is especially valuable, if not indispensable, and is aimed at accurate and efficient identification of the underlying genetic causes:

  • for the diagnosis of the specific type of disease
  • for assessing disease progression
  • for disease prevention in the extended family and to determine the risk for hereditary transmission
  • for customized treatment options or possible therapy

Generally, the identification of the specific type of ophthalmic disease through genetic testing undoubtedly facilitates the development and introduction of new and personalized treatments.

Tests included in the group